FI970102A - Menetelmä substiuoitujen sulfoksidien syntetisoimiseksi - Google Patents

Menetelmä substiuoitujen sulfoksidien syntetisoimiseksi Download PDF

Info

Publication number
FI970102A
FI970102A FI970102A FI970102A FI970102A FI 970102 A FI970102 A FI 970102A FI 970102 A FI970102 A FI 970102A FI 970102 A FI970102 A FI 970102A FI 970102 A FI970102 A FI 970102A
Authority
FI
Finland
Prior art keywords
synthesizing substituted
substituted sulfoxides
sulfoxides
synthesizing
substituted
Prior art date
Application number
FI970102A
Other languages
English (en)
Swedish (sv)
Other versions
FI970102A0 (fi
FI117672B (fi
Inventor
Erik Magnus Larsson
Urban Jan Stenhede
Henrik Soerensen
Unge Per Oskar Sverker Von
Hanna Kristina Cotton
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20394753&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI970102(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI970102A publication Critical patent/FI970102A/fi
Publication of FI970102A0 publication Critical patent/FI970102A0/fi
Application granted granted Critical
Publication of FI117672B publication Critical patent/FI117672B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI970102A 1994-07-15 1997-01-10 Menetelmä substituoitujen sulfoksidien syntetisoimiseksi FI117672B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9402510A SE504459C2 (sv) 1994-07-15 1994-07-15 Förfarande för framställning av substituerade sulfoxider
SE9402510 1994-07-15
SE9500818 1995-07-03
PCT/SE1995/000818 WO1996002535A1 (en) 1994-07-15 1995-07-03 Process for synthesis of substituted sulphoxides

Publications (3)

Publication Number Publication Date
FI970102A true FI970102A (fi) 1997-01-10
FI970102A0 FI970102A0 (fi) 1997-01-10
FI117672B FI117672B (fi) 2007-01-15

Family

ID=20394753

Family Applications (2)

Application Number Title Priority Date Filing Date
FI970102D FI117830B (fi) 1994-07-15 1997-01-10 Menetelmä substituoitujen sulfoksidien syntetisoimiseksi
FI970102A FI117672B (fi) 1994-07-15 1997-01-10 Menetelmä substituoitujen sulfoksidien syntetisoimiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI970102D FI117830B (fi) 1994-07-15 1997-01-10 Menetelmä substituoitujen sulfoksidien syntetisoimiseksi

Country Status (42)

Country Link
US (1) US5948789A (fi)
EP (1) EP0773940B2 (fi)
JP (1) JP3795917B2 (fi)
KR (1) KR100356252B1 (fi)
CN (1) CN1070489C (fi)
AR (1) AR003443A1 (fi)
AT (1) ATE242233T1 (fi)
AU (1) AU688074B2 (fi)
BR (1) BR9508292A (fi)
CA (1) CA2193994C (fi)
CZ (1) CZ297987B6 (fi)
DE (1) DE69530987T3 (fi)
DK (1) DK0773940T4 (fi)
DZ (1) DZ1911A1 (fi)
EE (1) EE03354B1 (fi)
EG (1) EG24534A (fi)
ES (1) ES2199998T5 (fi)
FI (2) FI117830B (fi)
HK (1) HK1008331A1 (fi)
HR (1) HRP950401B1 (fi)
HU (1) HU226361B1 (fi)
IL (1) IL114477A (fi)
IS (1) IS1772B (fi)
MA (1) MA23611A1 (fi)
MX (1) MX9700358A (fi)
MY (1) MY113180A (fi)
NO (1) NO312101B1 (fi)
NZ (1) NZ289959A (fi)
PL (1) PL186342B1 (fi)
PT (1) PT773940E (fi)
RU (1) RU2157806C2 (fi)
SA (1) SA95160294B1 (fi)
SE (1) SE504459C2 (fi)
SI (1) SI0773940T2 (fi)
SK (1) SK284059B6 (fi)
TN (1) TNSN95081A1 (fi)
TR (1) TR199500861A2 (fi)
TW (1) TW372971B (fi)
UA (1) UA47409C2 (fi)
WO (1) WO1996002535A1 (fi)
YU (1) YU49475B (fi)
ZA (1) ZA955724B (fi)

Families Citing this family (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
US6747155B2 (en) 1997-05-30 2004-06-08 Astrazeneca Ab Process
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
WO1999001454A1 (en) 1997-07-03 1999-01-14 Du Pont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704183D0 (sv) 1997-11-14 1997-11-14 Astra Ab New process
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
WO1999038513A1 (en) * 1998-01-30 1999-08-05 Sepracor Inc. R-lansoprazole compositions and methods
AU3967399A (en) * 1998-04-30 1999-11-16 Sepracor, Inc. S-rabeprazole compositions and methods
EP1073332A4 (en) * 1998-04-30 2005-06-15 Sepracor Inc R-RABEPRAZOL COMPOSITIONS AND METHODS
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
CN1087739C (zh) * 1998-12-28 2002-07-17 中国科学院成都有机化学研究所 光学纯的苯并咪唑类抗消化性溃疡药物的包结拆分制备法
SE9900274D0 (sv) * 1999-01-28 1999-01-28 Astra Ab New compound
TWI275587B (en) 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PT1191025E (pt) 1999-06-30 2005-09-30 Takeda Pharmaceutical Cristais de lansoprazol
WO2001014366A1 (fr) * 1999-08-25 2001-03-01 Takeda Chemical Industries, Ltd. Procede de preparation de derives optiquement actifs de sulfoxyde
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
AU2001252595A1 (en) * 2000-04-28 2001-11-12 Takeda Chemical Industries Ltd. Process for producing optically active sulfoxide derivative
ES2511774T3 (es) 2000-05-15 2014-10-23 Takeda Pharmaceutical Company Limited Formas cristalinas de (R)-lansoprazol
KR100869677B1 (ko) 2000-05-15 2008-11-21 다케다 야쿠힌 고교 가부시키가이샤 결정의 제조방법
WO2002012225A1 (fr) * 2000-08-04 2002-02-14 Takeda Chemical Industries, Ltd. Sels de composé à base de benzimidazole et leurs applications
DK1337525T3 (da) 2000-12-01 2011-09-19 Takeda Pharmaceutical Fremgangsmåde til krystallisering af (R)- eller (S)-lansoprazol
US7064214B2 (en) * 2001-04-13 2006-06-20 Apsinterm Llc Methods of preparing sulfinamides and sulfoxides
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
ES2286408T3 (es) * 2002-03-05 2007-12-01 Astrazeneca Ab Sales de alquilamonio de omeprazol e esomeprazol.
AU2003262375A1 (en) * 2002-04-22 2003-11-03 Sun Pharmaceutical Industries Limited Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
US7169793B2 (en) 2002-06-27 2007-01-30 Dr. Reddy's Laboratories Limited Process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
EP1552833B1 (en) 2002-10-16 2016-12-28 Takeda Pharmaceutical Company Limited Process for producing an amorphous optically active isomer of lansoprazole
EP1556043A1 (en) 2002-10-22 2005-07-27 Ranbaxy Laboratories, Ltd. Amorphous form of esomeprazole salts
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
BR0316702A (pt) * 2002-12-06 2005-10-18 Altana Pharma Ag xprocesso para preparação de (s)-pantoprazol
PT1578742E (pt) * 2002-12-06 2013-01-24 Nycomed Gmbh Processo para preparar compostos activos opticamente puros
FR2848555B1 (fr) 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
AR046245A1 (es) * 2002-12-16 2005-11-30 Ranbaxy Lab Ltd Sales de calcio de rabeprazol
WO2004056804A2 (en) 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
WO2004060263A2 (en) * 2003-01-07 2004-07-22 Ranbaxy Laboratories Limited Magnesium salt of imidazole derivative
TWI367759B (en) * 2003-02-20 2012-07-11 Santarus Inc A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
BRPI0407906A (pt) * 2003-02-28 2006-02-14 Ranbaxy Lab Ltd polimorfos de s-omeprazol
WO2004080961A2 (en) * 2003-03-12 2004-09-23 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous solids of pantoprazole and processes for their preparation
EP1611901B1 (en) * 2003-03-13 2013-07-10 Eisai R&D Management Co., Ltd. Preventive or remedy for teeth grinding
FR2852956B1 (fr) * 2003-03-28 2006-08-04 Negma Gild Procede de preparation enantioselective de derives de sulfoxydes
KR20060002878A (ko) * 2003-03-28 2006-01-09 지뎀 파마 술폭시화물 유도체의 광학 선택적 제조 방법
CN1842525A (zh) * 2003-05-05 2006-10-04 兰贝克赛实验室有限公司 苯并咪唑衍生物的钡盐
CA2528993A1 (en) 2003-06-10 2004-12-23 Teva Pharmaceutical Industries Ltd. Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0302382D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
AU2003288703A1 (en) * 2003-12-05 2005-06-24 Hetero Drugs Limited A process for the preparation of substitited pyridinylmethylsulfinyl- benzimidazole enantiomers
SE0400410D0 (sv) 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
PT1740571E (pt) 2004-04-28 2009-09-02 Hetero Drugs Ltd Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1748998B1 (en) * 2004-05-28 2010-01-27 Hetero Drugs Limited A novel stereoselective synthesis of benzimidazole sulfoxides
CN1960987A (zh) * 2004-06-02 2007-05-09 奥坦纳医药公司 制备吡啶－2－基甲基亚磺酰基－1h－苯并咪唑类化合物的方法
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
US20080249134A1 (en) * 2004-06-24 2008-10-09 Ursula Hohlneicher New Esomeprazole Sodium Salt Crystal Modification
NZ551970A (en) * 2004-06-24 2010-01-29 Astrazeneca Ab New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
FR2876101B1 (fr) * 2004-10-05 2007-03-02 Sidem Pharma Sa Sa Procede de preparation enantioselective de derives de sulfoxydes
DE602005016705D1 (de) * 2004-10-11 2009-10-29 Ranbaxy Lab Ltd Verfahren zur herstellung substituierter sulfoxide
US7592111B2 (en) * 2004-11-05 2009-09-22 Xerox Corporation Imaging member
CA2597632C (en) * 2005-03-25 2012-05-15 Livzon Pharmaceutical Group Inc. Substituted sulfoxide compounds, methods for preparing the same and use thereof
CN101098867B (zh) * 2005-03-25 2010-08-11 丽珠医药集团股份有限公司 取代的亚砜类化合物和其制备方法及用途
WO2006120520A1 (en) * 2005-05-06 2006-11-16 Glenmark Pharmaceuticals Limited Esomeprazole strontium salt, process for its preparation and pharmaceutical compositions containing same
ES2432563T3 (es) * 2005-06-08 2013-12-04 Lek Pharmaceuticals D.D. Solvato cristalino de omeprazol sódico
US20070043085A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of amorphous form of neutral esomeprazole
AU2006323245B2 (en) * 2005-12-05 2011-03-03 Astrazeneca Ab New process for the preparation of esomeprazole non-salt form
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
DE102005061720B3 (de) * 2005-12-22 2006-10-19 Ratiopharm Gmbh Enantioselektive Herstellung von Benzimidazolderivaten und ihren Salzen
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
ES2325336T3 (es) 2005-12-28 2009-09-01 Union Quimico-Farmaceutica, S.A. Procedimiento para la preparacion del enantiomero (s) de omeprazol.
CN1810803B (zh) * 2006-02-17 2010-11-17 中国科学院上海有机化学研究所 高对映体选择性制备(s)-奥美拉唑的方法
US7579476B2 (en) * 2006-02-24 2009-08-25 Praktikatalyst Pharma, Llc Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
US8063074B2 (en) * 2006-05-04 2011-11-22 Dr. Reddy's Laboratories Limited Polymorphic forms of esomeprazole sodium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
US8404853B2 (en) 2006-07-05 2013-03-26 Lupin Limited Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
CA2660112A1 (en) 2006-08-08 2008-02-14 Jubilant Organosys Limited Process for producing sulphoxide compounds
JP5492417B2 (ja) 2006-10-13 2014-05-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 胃酸分泌抑制作用を有するベンズイミダゾール化合物
JP2009196894A (ja) * 2006-10-13 2009-09-03 Eisai R & D Management Co Ltd スルフィニルベンズイミダゾール化合物またはその塩の製造方法
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
EP2125783A2 (en) 2007-02-21 2009-12-02 Cipla Limited Process for the preparation of esomeprazole magnesium dihydrate
WO2008149204A1 (en) * 2007-06-07 2008-12-11 Aurobindo Pharma Limited An improved process for preparing an optically active proton pump inhibitor
CN101323609B (zh) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
WO2009066321A2 (en) * 2007-10-03 2009-05-28 Ipca Laboratories Limited Process for optically active sulfoxide compounds
US8106210B2 (en) 2007-10-08 2012-01-31 Hetero Drugs Limited Polymorphs of esomeprazole salts
JP5629581B2 (ja) 2007-10-12 2014-11-19 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド 食物の摂取から独立した消化器疾患の治療方法
FR2925899B1 (fr) * 2007-12-27 2012-12-21 Sidem Pharma Sa Procede de preparation enantioselective de sulfoxydes.
CN101492459B (zh) * 2008-01-25 2011-04-27 山东轩竹医药科技有限公司 含烷氧乙酰基二氢异噁唑并吡啶化合物
CN101497603B (zh) * 2008-01-30 2012-11-07 山东轩竹医药科技有限公司 含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物
CL2009000547A1 (es) 2008-03-10 2010-05-07 Takeda Pharmaceuticals Co Forma cristalina de (r)-2[[[3-metil-4-(2,2,2-trifluoroetoxi)-2-piridinil]metil]sulfinil]-1h-bencimidazol, metodo de preparacion; composicion farmaceutica y su uso para la profilaxis o tratamiento de ulcera peptica, gastritis, esofagitis erosiva, esofago de barret,dispepsia funcional, cancer gastrico.
MX2010010049A (es) * 2008-03-18 2010-10-04 Reddys Lab Ltd Dr Proceso y polimorfos de dexlansoprazol.
CN101538264A (zh) * 2008-03-19 2009-09-23 中国科学院成都有机化学有限公司 手性亚砜类化合物的制备新方法
WO2009145368A1 (en) * 2008-05-27 2009-12-03 Sk Chemicals Co., Ltd. Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
WO2010039885A2 (en) * 2008-09-30 2010-04-08 Teva Pharmaceutical Industries Ltd. Crystalline forms of dexlansoprazole
EP2264024A1 (en) 2008-10-14 2010-12-22 LEK Pharmaceuticals d.d. Process for the preparation of enantiomerically enriched proton pump inhibitors
IT1391776B1 (it) 2008-11-18 2012-01-27 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo
CZ200990A3 (cs) * 2009-02-16 2010-08-25 Zentiva, K.S. Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
CZ2009172A3 (cs) * 2009-03-17 2010-09-29 Zentiva, K.S. Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
WO2010150276A2 (en) * 2009-06-02 2010-12-29 Sun Pharmaceutical Industries Limited Process for preparing sulphoxide compounds
IT1395118B1 (it) 2009-07-29 2012-09-05 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo cristallino
WO2011058569A1 (en) 2009-11-12 2011-05-19 Hetero Research Foundation Process for the resolution of omeprazole
CA2788147A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited Process for the preparation of crystalline forms of dexlansoprazole
KR20130087509A (ko) 2010-06-24 2013-08-06 씨아이피엘에이 엘티디. 덱스라베프라졸의 염 및 다형체
CN101914090B (zh) * 2010-08-13 2013-03-20 埃斯特维华义制药有限公司 左旋奥美拉唑的制备方法
CN102558150B (zh) * 2010-12-31 2014-03-12 正大天晴药业集团股份有限公司 取代亚砜化合物的合成方法
CN102321071B (zh) * 2011-07-20 2013-01-23 江苏奥赛康药业股份有限公司 一种高纯度埃索美拉唑钠的工业化生产方法
CN102977076A (zh) * 2011-09-02 2013-03-20 扬子江药业集团上海海尼药业有限公司 一种右兰索拉唑的制备方法
CN102329302A (zh) * 2011-10-22 2012-01-25 刘强 一种埃索美拉唑及其盐的制备方法
CN102408412A (zh) * 2011-10-25 2012-04-11 广东华南药业集团有限公司 高对映体选择性制备（s）- 奥美拉唑的方法
CN102432412A (zh) * 2011-10-28 2012-05-02 成都欣捷高新技术开发有限公司 一种手性亚砜类质子泵抑制剂或其可药用盐的制备方法
KR101300950B1 (ko) * 2011-10-31 2013-08-27 르노삼성자동차 주식회사 전기자동차의 공기 흡입 장치
WO2013140120A1 (en) 2012-03-22 2013-09-26 Cipla Limited Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole
CN102633776B (zh) * 2012-03-28 2014-06-18 中山市仁合药业有限公司 一种埃索美拉唑及其钠盐的制备方法
CN102659763B (zh) * 2012-04-27 2014-01-22 南京优科生物医药研究有限公司 一种右旋兰索拉唑合成与纯化的方法
CN103044402B (zh) * 2012-12-31 2015-01-14 康普药业股份有限公司 埃索美拉唑钠合成生产方法
CN103113351B (zh) * 2013-03-08 2015-01-21 苏州特瑞药业有限公司 一种光学纯手性亚砜类化合物的制备方法
CN104177336A (zh) * 2013-05-28 2014-12-03 上海汇伦生命科技有限公司 一种对映选择性合成右兰索拉唑的方法
WO2015155307A1 (en) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and proton pump inhibitors
EP2933002A1 (en) 2014-04-11 2015-10-21 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and proton pump inhibitors
EP2980086B1 (en) 2014-07-29 2016-06-15 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Efficient process for the preparation of esomeprazole (S)-binol complex
WO2016104668A1 (ja) * 2014-12-26 2016-06-30 国立大学法人 東京大学 光学活性のプロトンポンプ阻害化合物の製造方法
CN104610226A (zh) * 2014-12-31 2015-05-13 广东东阳光药业有限公司 一种右兰索拉唑的不对称氧化方法
ES2615637T3 (es) 2015-03-06 2017-06-07 F.I.S.- Fabbrica Italiana Sintetici S.P.A. Procedimiento mejorado para la purificación óptica del esomeprazol
CN105218391B (zh) * 2015-07-09 2017-11-21 天津青松华药医药有限公司 L‑酒石酸单酯单酰胺类化合物
CN105218392B (zh) * 2015-07-09 2017-11-21 天津青松华药医药有限公司 D‑酒石酸单酯单酰胺类化合物
CN105968097B (zh) * 2016-05-17 2019-05-03 杭州华东医药集团新药研究院有限公司 左旋泮托拉唑的工业化生产方法
CN106083818A (zh) * 2016-06-08 2016-11-09 扬子江药业集团有限公司 一种高纯度埃索美拉唑钠的制备方法
CN106366070B (zh) * 2016-08-10 2019-06-11 上海万巷制药有限公司 一种高纯度埃索美拉唑钠的制备方法
CN106632249A (zh) * 2016-09-30 2017-05-10 青岛云天生物技术有限公司 一种制备(s)‑泮托拉唑钠的方法
CN106632248A (zh) * 2016-09-30 2017-05-10 青岛云天生物技术有限公司 一种左旋泮托拉唑钠的制备工艺
CN106866630B (zh) * 2017-04-01 2018-08-07 上海华源医药科技发展有限公司 一种右兰索拉唑的制备方法
CN110746428A (zh) * 2019-10-29 2020-02-04 株洲千金药业股份有限公司 一种r型手性亚砜类化合物的制备方法
CN110698482A (zh) * 2019-10-29 2020-01-17 株洲千金药业股份有限公司 一种s型手性亚砜类化合物的制备方法
CN113845510A (zh) * 2020-06-27 2021-12-28 鲁南制药集团股份有限公司 一种埃索美拉唑的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution

Also Published As

Publication number Publication date
ES2199998T5 (es) 2011-03-16
EP0773940B1 (en) 2003-06-04
SE9402510L (sv) 1996-01-16
EP0773940A1 (en) 1997-05-21
IS1772B (is) 2001-06-01
WO1996002535A8 (en) 1999-12-23
SK284059B6 (sk) 2004-09-08
HRP950401A2 (en) 1997-10-31
KR970704731A (ko) 1997-09-06
JP3795917B2 (ja) 2006-07-12
HK1008331A1 (en) 1999-05-07
FI970102A0 (fi) 1997-01-10
ZA955724B (en) 1996-01-15
DK0773940T3 (da) 2003-09-15
IL114477A (en) 2001-07-24
AU2994895A (en) 1996-02-16
DE69530987T3 (de) 2011-07-07
SE504459C2 (sv) 1997-02-17
SI0773940T1 (en) 2004-02-29
SA95160294B1 (ar) 2006-07-31
PL186342B1 (pl) 2003-12-31
MX9700358A (es) 1997-04-30
EE03354B1 (et) 2001-02-15
BR9508292A (pt) 1997-12-23
SK4897A3 (en) 1997-08-06
HRP950401B1 (en) 2004-04-30
IS4406A (is) 1996-12-27
ATE242233T1 (de) 2003-06-15
RU2157806C2 (ru) 2000-10-20
CZ6497A3 (en) 1997-06-11
EP0773940B2 (en) 2010-11-17
AU688074B2 (en) 1998-03-05
WO1996002535A1 (en) 1996-02-01
CA2193994A1 (en) 1996-02-01
TNSN95081A1 (fr) 1996-02-06
DE69530987T2 (de) 2004-05-19
FI117672B (fi) 2007-01-15
TW372971B (en) 1999-11-01
CZ297987B6 (cs) 2007-05-16
AR003443A1 (es) 1998-08-05
US5948789A (en) 1999-09-07
CA2193994C (en) 2005-05-03
HU226361B1 (en) 2008-09-29
NO970153L (no) 1997-01-14
PT773940E (pt) 2003-10-31
JPH10504290A (ja) 1998-04-28
DZ1911A1 (fr) 2002-02-17
DK0773940T4 (da) 2011-02-07
KR100356252B1 (ko) 2002-11-18
EG24534A (en) 2009-08-30
IL114477A0 (en) 1995-11-27
UA47409C2 (uk) 2002-07-15
HUT76642A (en) 1997-10-28
FI117830B (fi) 2007-03-15
NO312101B1 (no) 2002-03-18
CN1157614A (zh) 1997-08-20
YU49475B (sh) 2006-05-25
DE69530987D1 (de) 2003-07-10
PL318165A1 (en) 1997-05-26
SE9402510D0 (sv) 1994-07-15
NO970153D0 (no) 1997-01-14
YU47695A (sh) 1998-07-10
MY113180A (en) 2001-12-31
MA23611A1 (fr) 1996-04-01
NZ289959A (en) 1998-01-26
TR199500861A2 (tr) 1996-06-21
CN1070489C (zh) 2001-09-05
SI0773940T2 (sl) 2011-02-28
ES2199998T3 (es) 2004-03-01

Similar Documents

Publication Publication Date Title
FI970102A (fi) Menetelmä substiuoitujen sulfoksidien syntetisoimiseksi
FI102474B1 (fi) Menetelmä moniarvoisten alkoholien valmistamiseksi
FI960278A (fi) Anataasititaanidioksidin valmistusmenetelmä
FI960145A (fi) Menetelmä sellun valmistamiseksi
DE69520558T2 (de) Halogenierungsverfahren
FI962370A0 (fi) Laite tissuen valmistamiseksi
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
FI972720A0 (fi) Menetelmä lamotrigiinin valmistamiseksi
FI964194A (fi) Laite puolipyöreän kourun valmistamiseksi
NO983068D0 (no) FremgangsmÕte for fremstilling av bis-syklopentadienyl-dien komplekser
FI971035A0 (fi) Biokonversioprosessi trans-hydroksisulfonin syntetisoimiseksi
DE69507032D1 (de) Chlorhydrin-verfahren
FI964229A (fi) Menetelmä doksorubisiinin valmistamiseksi
NO963187D0 (no) Fremgangsmåte for syntese av gamma-pyroner
FI960332A0 (fi) Menetelmä substituoitujan 4,6-diamino-5-syanopyrinidiinien valmistamiseksi
FI956058A (fi) Menetelmä glutaaridialdehydin valmistamiseksi
FI971964A0 (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
FI97725B (fi) Menetelmä diltiatseemin valmistamiseksi
FI951441A0 (fi) Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi
FI953181A (fi) Puriinien valmistusmenetelmä
FI950751A0 (fi) Menetelmä olefiinien valmistamiseksi
NO991193L (no) FremgangsmÕte for syntese av benzotiofener
FI951733A0 (fi) Vodkan valmistusmenetelmä
KR970006258A (ko) 디티오카바메이트 화합물의 제조방법
FI950517A (fi) Menetelmä lastulevyn valmistamiseksi

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ASTRAZENECA AB

Free format text: ASTRAZENECA AB

FG Patent granted

Ref document number: 117830

Country of ref document: FI

Effective date: 20070315

FG Patent granted

Ref document number: 117830

Country of ref document: FI

MA Patent expired